Summary Survival (5-and 10-year) and prognostic factors of all differentiated thyroid cancer patients (n= 1,055) occurring in Norway in 1970-79 are presented. The multivariate analysis (GLIM) revealed that stage and age were the only significant prognostic factors. Sex and histological type could not be proved to be of major prognostic value. The decline in relative survival with age was different in the three stages, appearing as a continuous decrease in stage 3, while in stage 1 the decrease was present only in patients older than 75 years.
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The Norwegian Thyroid Cancer Project was started in 1985. An important purpose was the study of aetiological factors, based on contrasts between incidence rates in different geographical regions in Norway (Thoresen et al., 1986) . Furthermore, analysis of thyroglobulin and selenium in premorbid serum-samples (The Janus Project) have recently been published (Thoresen et al., 1988; Glattre et al., 1988) and such results may also give clues to aetiology. The present study was undertaken to clarify the prognostic aspects of thyroid carcinoma in a representative and large study population, especially with respect to clinicopathological data.
Thyroid carcinomas are rather heterogeneous, ranging from anaplastic tumours, which kill most of the patients within one year, to well differentiated follicular and papillary types, with indolent behaviour and most often excellent prognosis. It has been known for a long time that certain clinical parameters and histopathological findings are of prognostic significance. In 1979 EORTC proposed a concept of risk groups in thyroid cancer (Byar et al., 1979) , based on sex, age, histology, T-category and distant metastases. Later, several groups have used multifactorial analysis to determine the individual contribution of such factors to the observed survival rates. However, a major problem has been the selection of patients for study, especially by time and place of treatment. Heterogeneity in histological judgement may also be present (Saxen et al., 1978) . The studies undertaken so far include small numbers of patients (Tennvall et al., 1985) or, in larger series, cases have been collected for up to 30 years and from several different hospitals and regions (Simpson et al., 1987) .
In the present report on 1,055 patients with differentiated thyroid cancer, all histological verified cases occurring in Norway in 1970-79 were included. This was made possible due to the Cancer Registry of Norway, which has almost complete information on incidence and excellent follow-up procedures. Thus, the main prognostic factors found by others have been re-evaluated in the Norwegian population using multivariate analysis and given an estimate for predictive significance.
Materials and methods
The Cancer Registry of Norway has received detailed information on nearly all cancer patients in Norway since 1953 (Cancer Registry of Norway, 1975) . This includes clinical data, histology and autopsy reports. Follow-up data on recurrences are regularly filed, and the time and cause of death are supplied once a year by the Central Bureau of Statistics. The histopathological service in Norway has been concentrated on a few university hospitals, and the health service in general is rather uniform in all parts of the country. About half of the patients were treated at The Norwegian Radium Hospital and a uniform method of assessment of lymph node and extension to the soft tissue of the neck was performed. The other half were mainly treated at four university hospitals, with mostly the same procedure for neck dissection.
In A multivariate analysis of 5-year relative survival was also performed using a generalised linear model as described by Hakulinen and Tenkanen (1987 With the above results in mind the non-parametric relation between age and stage is given in Figure 4 . The observed relative survival for both sexes and histological The single factor analysis showed an excellent prognosis of localised tumours after both 5 and 10 years of observation, independent of histological type. The importance of studying the relative survival, thereby obtaining an adjustment for unrelated deaths, is also stressed by this finding. Detailed data on the time and type of tumour recurrences, distant metastases and causes of death would be of great interest.
There were almost no changes in relative survival between 5 and 10 years in stage 1 and 2 tumours. This is somewhat unexpected in view of earlier data (Mazzaferri, 1987) but may be explained by deaths from other causes. It is, however, well known that even well differentiated thyroid cancer may develop metastases up to 15-20 years after first treatment. There are to our knowledge no data indicating an increase in excess deaths with time. When distant metastases are present, the prognosis is poorer, especially among females and in follicular carcinomas. Mortality is furthermore increased between 5 and 10 years after diagnosis, and this was most marked among males.
On the basis of univariate analysis of relative survival, both age and tumour stage had great impact on survival, while sex and histology showed minor variations. Age and stage were the only factors of prognostic importance obtained by the multivariate analysis. Additionally, these two factors were also interrelated. Localised disease presents in the younger patients. Several authors have confirmed the importance of stage (Hannequin et al., 1986; Tubiana et al., 1985; Simpson et al., 1987) . One of the advantages of the GLIM package is that it can handle large sets of data with rather small numbers in specific subgroups. We are aware that some of our subgroups (follicular carcinomas in males) fit this category.
It has, however, been debated whether lymph node involvement is of prognostic value. Joensuu et al. (1986) found that there was no significant difference in corrected survival between patients with nodal metastases at surgery and those without. Their material is, however, rather small with a total of only 200 patients distributed in three histological types. On the other hand, they claimed that invasion through the capsule was of significant value. Other studies support this, concluding that lymph node involvement is important for local recurrence but not for survival (Tubiana et al., 1985; Hannequin et al., 1986; Simpson et al., 1987) . Patients with regional lymph node involvement and extrathyroidal invasion were not analysed separately because of limited data. We have had a preliminary look at our registrated thyroid cancer occurring after 1980, and these data seem to indicate that soft tissue involvement of the neck carries a worse prognosis than nodal metastases.
Our results in the present paper also indicate no difference between stages I and 2 below 55 years of age, while those above 55 years had a slightly increased mortality. Finally, stage 3 patients had a clearly increased mortality among all age groups.
There seems to be full agreement among all authors that age is a major prognostic factor (Tubiana et al., 1985; Simpson et al., 1987) . It is more uncertain at which age the mortality risk increases. Some authors have observed a decline in relative survival after the age of 40 years (Cady et al., 1985) , while Tubiana et al. (1985) found this decline appearing some years later. The multifactorial analysis in the present investigation confirms age as a valuable prognostic factor and indicates that the major decline in relative survival appears after the age of 55 years, This is in keeping with Simpson et al. (1987) , who found more aggressive behaviour in patients beyond the age of 60. The discrepancies may partly be due to different groupings of age. Additionally, differences in stage distribution and histological type may also contribute to such conflicting results. We have shown the impact of age on survival to be clearly dependent on stage, and this may also indicate biological differences between tumours presenting in various stages. The multivariate analysis excludes patients over 75 years. This is done mainly because it is often a problem to give the correct expected survival in older age.
The histopathological typing in this study was based on the WHO classification from 1974 (Hedinger & Sobin, 1974) . The slides have not been reviewed, but all reports were examined to adjust the coding. Mixed tumours with both papillary and follicular elements were classified as papillary carcinomas. As stated by Simpson et al. (1987) , the distinction between papillary and follicular thyroid cancer may be of little more than academic interest. The follicular group was not subdivided with respect to differentiation grade. This may be an explanation of the lack of significant difference in survival between the two histological types. Tubiana et al. (1985) found no difference between papillary and well differentiated follicular carcinomas, while follicular tumours of lower differentiation had a worse prognosis. This is confirmed in the EORTC study (Byar et al., 1979) and by Hannequin et al. (1986) . In view of earlier reports (Saxen et al., 1978) , some follicular adenomas may also have been included, but these would only mask a difference of survival in stage 1 tumours. Additionally some papillary carcinomas may be incorrectly diagnosed as follicular carcinomas.
Sex as prognostic factor is also debated, although some studies claim that females have a better final outcome than males . We cannot confirm this finding. In our study, which included 803 females and 252 males, no sex differences persist after the multivariate analysis of patients below 75 years of age. This is partly confirmed in a paper by Simpson et al. (1987) .
One practical conclusion on the discrepancy between different prognostic studies could be that the prognostic factors may change from one population to another (Hannequin et al., 1986) . Thus one should be cautious in applying one set of prognostic factors to other populations. On the other hand, there seems to be full agreement that age and stage are independent and important prognostic factors. Studies on cellular DNA content have shown an increasing aneuploidy with age in both benign and malignant thyroid tumours (Joensuu et al., 1986) . This may be one explanation of the great prognostic importance of age. It therefore seems to be a clear biological difference between subgroups of thyroid -carcinomas. Further studies-on cause-specific mortality and tumour recurrences as well as extensive morphological studies are now in progress in Norway.
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